Latest Dynavax Technologies Corporation Stories
ReportsnReports.com adds Hepatitis B Global Clinical Trials Review H2 2014 to its store.
Findings Could Lead to Lower Doses of Medication for Lupus Patients, Reducing Serious Side Effects DALLAS, July 12 /PRNewswire-USNewswire/ -- Two immune system proteins could be the culprit behind many lupus patients' resistance to widely used steroid treatments, scientists with the Baylor Research Institute (BRI) in Dallas announced today.
- Small missiles, especially grape, canister, fragments of iron, and the like, when fired, as upon an enemy at close quarters.
- To fire mitraille at.